SEC Filings

10-12G/A
AMSURG CORP filed this Form 10-12G/A on 11/03/1997
Entire Document
 
<PAGE>   105
 
   
                                  AMSURG CORP.
    
                   UNAUDITED PRO FORMA FINANCIAL INFORMATION
   
                      NINE MONTHS ENDED SEPTEMBER 30, 1997
    
                      (IN THOUSANDS EXCEPT PER SHARE DATA)
 
   

<TABLE>
<CAPTION>
                                                                  1997 INDIVIDUALLY                    PRO
                                     AMSURG      THE ENDOSCOPY      INSIGNIFICANT       PRO FORMA     FORMA
                                   HISTORICAL   CENTER, INC.(A)   ACQUISITIONS(A)(B)   ADJUSTMENTS   COMBINED
                                   ----------   ---------------   ------------------   -----------   --------
<S>                                <C>          <C>               <C>                  <C>           <C>
Revenues.........................   $41,163          $2,090              $586            $   (55)(2) $43,784
                                    -------          ------            ------            -------     -------
Expenses:
  Salaries and benefits..........    12,552             470               128                (43)(3)  13,107
  Other operating expenses.......    14,564             501               215                (20)(4)  15,260
  Depreciation and
     amortization................     3,511              --                17                180(5)    3,708
  Interest.......................     1,141              --                 1                223(6)    1,365
  Net loss on sale of
     assets(c)...................     1,494              --                --                 --       1,494
  Distribution cost(d)...........       458              --                --                 --         458
                                    -------          ------            ------            -------     -------
          Total expenses.........    33,720             971               361                340      35,392
Income before minority interest
  and income taxes...............     7,443           1,119               225               (395)      8,392
  Minority interest..............     6,447              --                --                625(7)    7,072
                                    -------          ------            ------            -------     -------
Income before income taxes.......       996           1,119               225             (1,020)      1,320
  Income tax expense.............     1,279              --                --                130(8)    1,409
                                    -------          ------            ------            -------     -------
Net income (loss)................      (283)          1,119               225             (1,150)        (89)
  Accretion of preferred stock
     discount....................       210              --                --                 --         210
                                    -------          ------            ------            -------     -------
Net income (loss) attributable to
  common stockholders............   $  (493)         $1,119              $225            $(1,150)    $  (299)
                                    =======          ======            ======            =======     =======
Net income per share attributable
  to common stockholders(1)......   $ (0.05)                                                         $ (0.03)
                                    =======                                                          =======
Weighted average common shares
  and equivalents(1).............     9,437                                                  134(9)    9,571
</TABLE>

    
 
- ---------------
 
(a) From January 1, 1997 to date of acquisition.
   
(b) Two acquisitions were completed in early 1997 and therefore the results of
    their operations for the nine months ended September 30, 1997 are included
    in the AmSurg historical amounts.
    
   
(c) Reflects a loss attributable to the sale of a partnership interest, net of a
    gain on the sale of a surgery center building and equipment, which had an
    impact of $0.16 per share on the historical and pro forma results of
    operations for the nine months ended September 30, 1997.
    
   
(d) Reflects costs incurred to date related to the distribution of the Company's
    common stock, which had an impact of $0.05 per share on the historical and
    pro forma results of operations for the nine months ended September 30,
    1997.
    
 
                                      F-18